The FDA today announced that Medtronic (NYSE:MDT) has expanded the Class I recall of its MiniMed 600 series insulin pumps.
Medtronic today notified customers by email and phone that the recall has been expanded to replace all MiniMed 600 series insulin pumps that contain the clear container ring.
The Fridley, Minnesota-based company first warned of safety problems with the pumps in November 2019. The recall initially involved 322,005 pumps — MiniMed 630G and MiniMed 670G — in the U.S.
Get the full story at our sister site, Drug Delivery Business News.